Stay updated on PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Sign up to get notified when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.

Latest updates to the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe Record History gains a new Revision: v3.7.0 entry. It also removes Revision: v3.6.6, updating the version history to reflect the latest change.SummaryDifference0.1%

- Check37 days agoChange DetectedA new revision entry v3.6.6 is added to the study record history, and the previous entry v3.6.5 is removed. This updates the page's version history to reflect the latest revision.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history now includes a new revision entry, v3.6.5. The previous revision, v3.6.4, is removed from the visible history, indicating an administrative update to the record version rather than substantive trial changes.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.6.4 was added to the Record History. The prior v3.6.3 entry was removed.SummaryDifference0.1%

- Check94 days agoChange DetectedA new revision entry, v3.6.3, was added to the study's record history. The previous revision, v3.6.2, was removed from the current history view.SummaryDifference0.1%

- Check101 days agoChange DetectedThe Record History shows a new Revision: v3.6.2 entry replacing v3.6.0, representing a new software release for the study record interface.SummaryDifference0.1%

Stay in the know with updates to PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC
Enter your email address, and we'll notify you when there's something new on the PHOEBE Trial: Pyrotinib vs Lapatinib in HER2+ MBC page.